Concepedia

Matthew Maurer

MM

Statistics

Publications

35

Citations

4.4K

H-Index

26

Active since

1970

Affiliations

Columbia University Irving Medical Center(Current)

Columbia University

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Bristol-Myers Squibb (United States)

Matthew Maurer is an author at Columbia University Irving Medical Center specializing in oncology, medicine, and molecular oncology.

Publications per year

1970–2025

35

Publications

35

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Toni K. Choueiri, Thomas Powles, Mauricio Burotto et al. · New England Journal of Medicine · 2021 · 1.7K citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair

Lao H. Saal, Sofia K. Gruvberger-Saal, C. Persson et al. · Nature Genetics · 2007 · 351 citations · Full text

Life Sciences, Genetics, Oncology +15

A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival

Benjamin D. Hopkins, Barry Fine, Nicole Steinbach et al. · Science · 2013 · 316 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a

Barry Fine, Cindy Hodakoski, Susan Koujak et al. · Science · 2009 · 245 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti–PD-1/PD-L1 therapy.

Paolo A. Ascierto, Ignacio Melero, Shailender Bhatia et al. · Journal of Clinical Oncology · 2017 · 240 citations

Life Sciences, Immunology, Oncology +17

1–5 of 35